The Pharmacokinetics and Pharmacodynamics of Hemp-based Topical Cannabinoid Products

计划入组 47 人 · 首次发布于 2021 年 2 月 5 日

Determination of Cannabinoid and Cannabinoid Metabolite Levels in Healthy Volunteers

首次发布于 2021 年 8 月 9 日

Effect of Cannabinoid (THC / CBD 50%) on Hyperalgesia in Patients With Deep Endometriosis

计划入组 10 人 · 首次发布于 2019 年 3 月 14 日

Cannabinoid based product

CBIS-OS-001

Cannabinoid based therapies (CNBX Pharmaceuticals)

Oxford Cannabinoid Technologies Holdings Plc

United Kingdom

EVIDENCE-BASED PRACTICE INSTITUTE, INC.

United States

National Evidence-based Healthcare Collaborating Agency

South Korea

Ananda Developments Advances Cannabinoid Medicines in Phase III Epilepsy Trials

Two Major Cannabinoid Companies Achieve European CEP Certification for Pharmaceutical-Grade CBD

MMJ International CEO Alleges DEA Obstruction of FDA-Authorized Cannabis Research for Neurological Diseases